Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

If You Think the Fed is Wrong, Buy This Gold Stock

Whenever you see a stock that's resisting a broad market sell-off - or that's not getting caught up in a downdraft in its own sector - you've found an investment opportunity that warrants a much closer look.

That's a piece of market wisdom we've shared with you folks before - most recently with Enanta Inc. (Nasdaq: ENTA), a biotech we recommended on Jan. 2. Just four weeks later, on Jan. 31, with the stock already up 15%, we noticed the vaccine-maker's shares were resisting a broad market sell-off that was inflicting particular pain on biotechs. So we urged you to take a closer look.

As of Wednesday's market close, Enanta's shares were up 40% from our initial recommendation price.

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK